Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Hepatol. Sep 28, 2016; 8(27): 1137-1148
Published online Sep 28, 2016. doi: 10.4254/wjh.v8.i27.1137
Table 1 Characteristics of the study groups at baseline (pre-intervention) and after 6 mo of energy restriction or exercise training (post-intervention)
Energy restriction (n = 6)
Exercise training (n = 10)
PrePostPrePost
Age (yr)45.5 ± 13.551.8 ± 6.7
Gender (M:F)3:37:3
BMI (kg/m2)33.5 ± 9.030.0 ± 7.0a31.2 ± 3.230.8 ± 3.5
Fat-mass (%)38 ± 935 ± 11b36 ± 733 ± 6a
Fat-free mass (kg)54.1 ± 12.351.3 ± 11.863.1 ± 14.364.4 ± 14.2a
Waist (cm)106 ± 1690 ± 13110 ± 14105 ± 13a
Systolic blood pressure (mmHg)126 ± 13118 ± 13a139 ± 19137 ± 18
Subcutaneous adipose tissue (cm2)358 ± 282268 ± 202b322 ± 116298 ± 117a
Visceral adipose tissue (cm2)202 ± 110203 ± 56b182 ± 67117 ± 36a
Diastolic blood pressure (mmHg)83 ± 875 ± 1288 ± 1183 ± 10
Triglycerides (mmol/L)1.6 ± 0.81.1 ± 0.42.0 ± 1.32.0 ± 0.2
HDL cholesterol (mmol/L)0.9 ± 0.21.0 ± 0.31.0 ± 0.21.1 ± 0.2a
LDL cholesterol (mmol/L)3.5 ± 0.83.0 ± 0.63.2 ± 1.13.1 ± 1.0
VLDL cholesterol (mmol/L)0.7 ± 0.30.5 ± 0.2b0.9 ± 0.60.7 ± 0.5
Free fatty acids (mmol/L)0.59 ± 0.150.63 ± 0.230.59 ± 0.170.62 ± 0.25
Glucose (mmol/L)5.2 ± 0.35.0 ± 0.75.5 ± 0.55.3 ± 0.4
Insulin (mU/L)18 ± 1810 ± 524 ± 2312 ± 10
M-value (mg/kgFFM per minute)4.2 ± 1.45.2 ± 1.54.0 ± 0.95.2 ± 1.6a
hsCPR (mg/L)4.9 ± 3.72.0 ± 1.63.9 ± 3.61.5 ± 1.3
Alanine aminotransferase (U/L80 ± 6555 ± 5554 ± 1949 ± 28
Aspartate aminotransferase (U/L)40 ± 2228 ± 1638 ± 1139 ± 22